Literature DB >> 23265438

Defects in the oval fossa: morphologic variations and impact on transcatheter closure.

Joseph J Vettukattil1, Zaheer Ahmed, Anthony P Salmon, Tomothy Mohun, Robert H Anderson.   

Abstract

BACKGROUND: Incomplete formation of the partition between the two atrial chambers in the region of the oval fossa results in a range of defects, which extend from patent foramen ovale to large secundum atrial septal defects (ASDs). There is wide variation in the morphology of the latter lesions. The spatial orientation of the margins of ASDs relative to the persisting flap valve is not easily definable with standard echocardiographic imaging. Careful evaluation of the morphology is essential in optimizing successful transcatheter closure to minimize complications. The advent of three-dimensional transesophageal echocardiography has changed the understanding of the morphology of these defects and facilitated successful percutaneous closure.
METHODS: Since 2007, over a 4-year period, transcatheter closure of ASDs was performed in 105 patients.
RESULTS: During the study period, there were two instances of embolization of the device. The morphology of the defects in the patients with embolization was evaluated carefully, and an unusual spiral configuration of the flap valve relative to the rims of the oval fossa was noted. These findings were then found in four additional patients and serve as the focus of this report. To facilitate understanding of the unusual morphology, the clinical findings were compared with images showing the mechanism of development of the atrial septum in the mouse, revealing a striking similarity.
CONCLUSIONS: Although uncommon, spiral spatial orientation of the margins of ASDs predisposes to embolization of devices used for percutaneous closure. Standard cross-sectional techniques have limited use in identifying this variation. Understanding of the development of the atrial septum in the mouse heart may help explain the morphogenesis of the defect and the mechanism predisposing to embolization.
Copyright © 2013 American Society of Echocardiography. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23265438     DOI: 10.1016/j.echo.2012.10.019

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  5 in total

1.  Appropriate selection of echocardiographic guidance for transcatheter atrial septal defect closure.

Authors:  Michiyo Yamano; Tetsuhiro Yamano; Takeshi Nakamura; Kan Zen; Hirokazu Shiraishi; Takeshi Shirayama; Satoaki Matoba
Journal:  Int J Cardiovasc Imaging       Date:  2020-02-10       Impact factor: 2.357

2.  Successful percutaneous closure of spiral atrial septal defect.

Authors:  Mashail Alobaidan; A Saleem; H Abdo; J Simpson
Journal:  Echo Res Pract       Date:  2015-01-07

Review 3.  Autopsy in adults with congenital heart disease (ACHD).

Authors:  Annalisa Angelini; Cira di Gioia; Helen Doran; Marny Fedrigo; Rosa Henriques de Gouveia; Siew Yen Ho; Ornella Leone; Mary N Sheppard; Gaetano Thiene; Konstantinos Dimopoulos; Barbara Mulder; Massimo Padalino; Allard C van der Wal
Journal:  Virchows Arch       Date:  2020-04-07       Impact factor: 4.064

Review 4.  Advances in Percutaneous Patent Foramen Ovale Closure: From the Procedure to the Echocardiographic Guidance.

Authors:  Simona Sperlongano; Mario Giordano; Giovanni Ciccarelli; Giuseppe Bassi; Marco Malvezzi Caracciolo D'Aquino; Carmen Del Giudice; Gianpiero Gaio; Antonello D'Andrea; Adriana Postolache; Maurizio Cappelli Bigazzi; Giancarlo Scognamiglio; Berardo Sarubbi; Maria Giovanna Russo; Paolo Golino; Patrizio Lancellotti
Journal:  J Clin Med       Date:  2022-07-11       Impact factor: 4.964

5.  Clinical Significance of Septal Malalignment for Transcatheter Closure of Atrial Septal Defect.

Authors:  Yoichi Takaya; Teiji Akagi; Koji Nakagawa; Rie Nakayama; Takashi Miki; Nobuhisa Watanabe; Norihisa Toh; Hiroshi Ito
Journal:  J Interv Cardiol       Date:  2020-03-03       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.